Funder: Alliance for Cancer Gene Therapy
Due Dates: May 16, 2025 (LOI) | August 22, 2025 (Full Application, by invitation)
Funding Amounts: Up to $500,000 total over 2–3 years (includes max 10% indirect costs)
Summary: Supports innovative cell and gene therapy research for breast cancer, targeting novel approaches and unmet clinical needs.
Key Information: LOI required; only invited applicants may submit a full application.